Cardinal Health, Inc. Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Cardinal Health, Inc. (CAH) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of -$6.00 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-11.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-11
- Cardinal Health, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-09-30 was -$2.00M, a 122.22% decline year-over-year.
- Cardinal Health, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-09-30 was $9.00M.
- Cardinal Health, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-09-30 was -$5.00M.
- Cardinal Health, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2022-09-30 was -$15.00M.
- Cardinal Health, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2026 was -$6.00M.
- Cardinal Health, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2025 was -$3.00M.
- Cardinal Health, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was -$9.00M.
- Cardinal Health, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was -$8.00M.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$6.00M 10-K · filed 2026-08-11 | |||
| 2025-12-31 | -$5.00M 10-Q · filed 2026-02-05 | |||
| 2025-09-30 | -$2.00M 10-Q · filed 2025-10-30 | |||
| 2025-06-30 | -$3.00M 10-K · filed 2026-08-11 | |||
| 2025-03-31 | $1.00M 10-Q · filed 2025-05-01 | |||
| 2024-12-31 | -$3.00M 10-Q · filed 2026-02-05 | |||
| 2024-09-30 | $9.00M 10-Q · filed 2025-10-30 | |||
| 2024-06-30 | -$9.00M 10-K · filed 2026-08-11 | |||
| 2024-03-31 | -$7.00M 10-Q · filed 2025-05-01 | |||
| 2023-12-31 | $1.00M 10-Q · filed 2025-01-30 | |||
| 2023-09-30 | -$5.00M 10-Q · filed 2024-11-01 | |||
| 2023-06-30 | -$8.00M 10-K · filed 2025-08-12 | |||
| 2023-03-31 | -$1.00M 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | -$1.00M 10-Q · filed 2024-02-01 | |||
| 2022-09-30 | -$15.00M 10-Q · filed 2023-11-03 | |||
| 2022-06-30 | -$25.00M 10-K · filed 2024-08-14 | |||
| 2022-03-31 | -$13.00M 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | -$11.00M 10-Q · filed 2023-02-02 | |||
| 2021-09-30 | -$5.00M 10-Q · filed 2022-11-04 | |||
| 2021-06-30 | $11.00M 10-K · filed 2023-08-15 | |||
| 2021-03-31 | $8.00M 10-Q · filed 2022-05-05 | |||
| 2020-06-30 | -$13.00M 10-K · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |